1. Home
  2. ARDT vs BCRX Comparison

ARDT vs BCRX Comparison

Compare ARDT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDT
  • BCRX
  • Stock Information
  • Founded
  • ARDT 2001
  • BCRX 1986
  • Country
  • ARDT United States
  • BCRX United States
  • Employees
  • ARDT N/A
  • BCRX N/A
  • Industry
  • ARDT
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ARDT
  • BCRX Health Care
  • Exchange
  • ARDT NYSE
  • BCRX Nasdaq
  • Market Cap
  • ARDT 1.7B
  • BCRX 1.7B
  • IPO Year
  • ARDT 2024
  • BCRX 1994
  • Fundamental
  • Price
  • ARDT $14.57
  • BCRX $9.92
  • Analyst Decision
  • ARDT Buy
  • BCRX Buy
  • Analyst Count
  • ARDT 13
  • BCRX 8
  • Target Price
  • ARDT $20.69
  • BCRX $16.75
  • AVG Volume (30 Days)
  • ARDT 299.3K
  • BCRX 5.7M
  • Earning Date
  • ARDT 05-06-2025
  • BCRX 05-05-2025
  • Dividend Yield
  • ARDT N/A
  • BCRX N/A
  • EPS Growth
  • ARDT 887.41
  • BCRX N/A
  • EPS
  • ARDT 1.56
  • BCRX N/A
  • Revenue
  • ARDT $6,024,260,000.00
  • BCRX $503,485,000.00
  • Revenue This Year
  • ARDT $8.18
  • BCRX $27.64
  • Revenue Next Year
  • ARDT $5.58
  • BCRX $13.42
  • P/E Ratio
  • ARDT $9.52
  • BCRX N/A
  • Revenue Growth
  • ARDT 8.91
  • BCRX 41.67
  • 52 Week Low
  • ARDT $11.31
  • BCRX $5.06
  • 52 Week High
  • ARDT $20.72
  • BCRX $11.11
  • Technical
  • Relative Strength Index (RSI)
  • ARDT N/A
  • BCRX 65.51
  • Support Level
  • ARDT N/A
  • BCRX $8.28
  • Resistance Level
  • ARDT N/A
  • BCRX $11.11
  • Average True Range (ATR)
  • ARDT 0.00
  • BCRX 0.51
  • MACD
  • ARDT 0.00
  • BCRX 0.25
  • Stochastic Oscillator
  • ARDT 0.00
  • BCRX 69.17

About ARDT ARDENT HEALTH PARTNERS INC

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services predominantly through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operate across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: